HANNAH JAZDZEWSKI: Open Payments
NPI 1194441113 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$328 in 17 payments from 8 companies in 2025. Trend: 2023 $496 · 2024 $401 · 2025 $328
Food & beverage: $328
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $115 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $51 |
| Exact Sciences Corporation | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $19 |
| Amgen Inc. | 1 | $17 |
Products named: REXULTI, CAPLYTA, Cologuard Collection Kit, OFEV, UZEDY, OTEZLA, BREZTRI, FARXIGA.
Industry payments across KY — which companies pay providers there.
